Clik here to view.
Thank you – new readers and old friends Plus OPK / ROX Dr. Frost Update
This morning my second monitor ( two weeks old HP Pavilion went into sleep mode and won’t recognize the connection to my other screen. Any help would be appreciated. At the same time – I want to say I...
View ArticleClik here to view.
OPK, ROX, LTS , Dr. Phillip Frost Update
Castle Brand holders cheer the Frost Upsurge We track three major positions for Jack A. Bass Managed Accounts and after the ROX haircut we are happy to see our profits regrowing at a faster trading...
View ArticleClik here to view.
OPKO Health Oppenheimer Coverage / Rating Outperform
Investment analysts at Oppenheimer assumed coverage on shares of Opko Health (NYSE:OPK) in a note issued to investors on Thursday, Analyst Ratings Network.com reports. The firm set an “outperform”...
View ArticleClik here to view.
OPKO Health News Release – helps stem drift
American Urological Association (AUA) Accepts 4Kscore Test Clinical Study for Plenary Presentation at 2014 Annual Meeting Jack A. Bass Managed accounts holds OPK OPKO HEALTH INC(OPK:NYSE, US)...
View ArticleClik here to view.
TINY New Investment
Much like our interest in Opko Health ( OPK) is a new ( to us ) company that invests in other companies . By not investing in pure research OPK hopes to be at the stage – or closer to the stage of...
View ArticleClik here to view.
Motley Fool Damns OPKO with Faint Praise
Opko Health (NYSE: OPK) – Friday March 28 Finally, we have hybrid diagnostic and pharmaceutical product developer Opko Health, which offers a great degree of promise thanks to a pipeline that spans a...
View ArticleClik here to view.
Reversed Our Positions on Dr. Phillip Frost
Sold out of ROX at an average of $ 1.15 Is America going to stop drinking ? CASTLE BRANDS INC(ROX:NYSE MKT LLC, US) 0.8599USD0.0831(-8.81%)Volume: Above Average As of 30 Apr 2014 at 12:53 PM EDT....
View ArticleClik here to view.
OPKO Health QRT. Report
OPKO Announces First Quarter Operating Results 4Kscore™ Test successfully completed clinical validation study and launched on March 31, 2014 All RAYALDEE™ Phase 3 clinical trials have completed...
View ArticleClik here to view.
Why Investors Love Drug Companies
JAMES SUROWIECKI APRIL 28, 2014 The New Yorker Few people have done better in the recent stock boom than biotech investors. Biotech was the best-performing market sector last year, and in the past...
View ArticleClik here to view.
Opko Health : One To Watch In 2016 – Motley Fool
What: After reporting an upside surprise in third-quarter earnings and the mid-month launch of its first royalty-producing drug by partner Tesaro (NASDAQ:TSRO), shares in Opko Health (NYSE:OPK)...
View Article
